Brief: India's Marksans Pharma June Quarter Consol Profit Falls
09/08/2019 09:10
Aug 9 (Reuters) - Marksans Pharma Ltd MARK.NS :
* JUNE QUARTER CONSOL PROFIT 224.8 MILLION RUPEES VERSUS
248.8
MILLION RUPEES YEAR AGO
* JUNE QUARTER CONSOL REVENUE FROM OPERATIONS 2.45 BILLION
RUPEES
VERSUS 2.35 BILLION RUPEES YEAR AGO
Source text for Eikon: ID:nBSEFRP5s
Further company coverage: MARK.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Marksans Pharma
See all newsIndia's Marksans Pharma jumps to over 18-month high after more than doubling quarterly profit
Brief: Marksans Pharma Ltd To Acquire 100% Of Netherlands-Based Qliniq B.V
India's Marksans Pharma jumps to 10-month high after Q4 profit rise
Brief: Marksans Pharma March-Quarter Consol Net Profit 1.48 Billion Rupees
Brief: Marksans Pharma Ltd Receives USFDA Approval For Benzonatate Capsules USP, 100 Mg & 200 Mg